首页> 美国卫生研究院文献>Biochemical Journal >Structure of a truncated human surfactant protein D is less effective in agglutinating bacteria than the native structure and fails to inhibit haemagglutination by influenza A virus.
【2h】

Structure of a truncated human surfactant protein D is less effective in agglutinating bacteria than the native structure and fails to inhibit haemagglutination by influenza A virus.

机译:截短的人表面活性剂蛋白D的结构在凝集细菌中的效果不如天然结构并且不能抑制A型流感病毒的血凝作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Surfactant protein D (SP-D) is a lung-specific protein that is synthesized and secreted by lung epithelial cells and is believed to play an important role in lung host defence. This protein belongs to the C-type lectin family, which is characterized by an N-terminal cysteine-rich domain, a collagen-like domain, a neck domain and a carbohydrate recognition domain (CRD). To elucidate the biological actions of this animal lectin against such pathogens as micro-organisms, the biological activities of a recombinant partial SP-D lacking a collagen-like domain were examined. A recombinant human SP-D, consisting of a short collagen region (two repeats of Gly-Xaa-Yaa amino acid sequences), the neck domain and the CRD, was expressed in Escherichia coli. The recombinant SP-D was purified on a nickel column and then on a maltose-agarose column. This protein can form a trimeric structure owing to the neck domain and exhibits sugar-binding activity and specificity similar to those of native human SP-D. The recombinant SP-D caused dose-dependent and calcium-dependent agglutination of E. coli Y1088. The agglutination titre (the concentration required to achieve a 50% decrease in light transmission by agglutination) of recombinant SP-D was approx. 6-fold that of native SP-D. As for conglutination, the recombinant trimeric conglutinin required 8-16-fold higher concentrations than the native counterpart. In haemagglutination inhibition (HI) of influenza A virus, although native and recombinant conglutinin showed similar levels of HI activity, the recombinant SP-D was unable to inhibit haemagglutination, even at a concentration approx. 120-fold that of the native SP-D. The lectin precipitation and lectin blot assays showed that the truncated SP-D could bind to influenza A virus as well as native SP-D did. These results indicate that the agglutination activity of trimeric collectins can be largely retained, and furthermore that the oligomeric structure with several hands at opposite sites can enhance agglutination activity. The difference in HI activity against influenza A virus between native and recombinant SP-D suggests that SP-D uses a different mechanism from that of conglutinin to inhibit viral haemagglutination.
机译:表面活性剂蛋白D(SP-D)是一种肺特异性蛋白,由肺上皮细胞合成和分泌,被认为在肺宿主防御中起重要作用。该蛋白属于C型凝集素家族,其特征是富含N端的半胱氨酸结构域,胶原样结构域,颈部结构域和碳水化合物识别结构域(CRD)。为了阐明该动物凝集素对诸如微生物等病原体的生物学作用,研究了缺乏胶原样结构域的重组部分SP-D的生物学活性。在大肠杆菌中表达了由短胶原区域(Gly-Xaa-Yaa氨基酸序列的两个重复),颈部结构域和CRD组成的重组人SP-D。重组SP-D在镍柱上纯化,然后在麦芽糖-琼脂糖柱上纯化。由于颈部结构域,该蛋白质可形成三聚体结构,并表现出与天然人SP-D相似的糖结合活性和特异性。重组SP-D引起大肠杆菌Y1088的剂量依赖性和钙依赖性凝集。重组SP-D的凝集滴度(通过凝集使光透射率降低50%所需的浓度)为约1。是本地SP-D的6倍。至于凝集,重组三聚体凝集素需要的浓度比天然对应物高8-16倍。在甲型流感病毒的血凝抑制作用(HI)中,尽管天然和重组凝集素显示出相似的HI活性水平,但重组SP-D甚至在大约50毫克的浓度下也无法抑制血凝反应。是原生SP-D的120倍。凝集素沉淀和凝集素印迹分析表明,与天然SP-D一样,截短的SP-D可以与A型流感病毒结合。这些结果表明,三聚体集合蛋白的凝集活性可以被大大保留,此外,在相反位置用几只手的寡聚结构可以增强凝集活性。天然SP-D和重组SP-D在针对A型流感病毒的HI活性上的差异表明,SP-D使用与凝集素不同的机制来抑制病毒血凝。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号